EVs transfected with an miR-133b mimic by the Exo-Fect [125] and M2 polarized bone marrow-derived macrophages derived EVs packaged with miR-690 [126] both enhanced glucose tolerance, insulin sensitivity, and thus provided a new insulin-sensitizing agent for the treatment of metabolic diseases (Table 6). The gene discussed is INS; the disease is metabolic disease.